Releev Cold Sore Treatment Liquid
NDC Package 63287-419-33
Package Information
Releev Cold Sore Treatment (benzalkonium chloride) liquids is sHAKE WELL (Adults and children 12 years of age or older) apply to clean, dry, affected area 3-4 times per day by dabbing and pressing solution into the area well. This formulation utilizes a liquid delivery system. Marketed by Merix Pharmaceutical Corp., this product is identified by NDC 63287-419 and is authorized under FDA application M003.
Identification & Billing
- RxCUI: 1049254 - benzalkonium chloride 0.13 % Topical Solution
- RxCUI: 1049254 - benzalkonium chloride 1.3 MG/ML Topical Solution
- RxCUI: 1095485 - Releev Cold Sore 0.13 % Topical Solution
- RxCUI: 1095485 - benzalkonium chloride 1.3 MG/ML Topical Solution [Releev Cold Sore]
- RxCUI: 1095485 - Releev Cold Sore 1.3 MG/ML Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63287 - Merix Pharmaceutical Corp.
- 63287-419 - Releev Cold Sore Treatment
- 63287-419-33 - 1 BOTTLE, DROPPER in 1 BLISTER PACK / 3 mL in 1 BOTTLE, DROPPER
- 63287-419 - Releev Cold Sore Treatment
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63287-419). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63287-419-33 identifies a specific commercial package of 1 bottle, dropper in 1 blister pack / 3 ml in 1 bottle, dropper of Releev Cold Sore Treatment, a human over the counter drug labeled by Merix Pharmaceutical Corp.. This liquid is formulated for topical use and contains benzalkonium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Merix Pharmaceutical Corp. on June 01, 2006. The current certification is valid through December 31, 2027.
How is this Merix Pharmaceutical Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63287041933. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.